CD44 and stroke disorder: Analysis of these 14 genes revealed Spp1 and its signaling pathway members, namely, Cd44, Timp1 and Mmp12 upregulated in all the NVU cells, suggesting Spp1 as a therapeutic target in stroke (Fig. 3c–g).